MP9-09 PREDICTORS OF CONTINUED SMOKING AFTER THE DIAGNOSIS OF A GENITOURINARY MALIGNANCY

Abstract

You have accessJournal of UrologyGeneral & Epidemiological Trends & Socioeconomics: Evidence-based Medicine & Outcomes II1 Apr 2015MP9-09 PREDICTORS OF CONTINUED SMOKING AFTER THE DIAGNOSIS OF A GENITOURINARY MALIGNANCY Stephen Hurley, Saumya Easaw, Andrew Drago, Christina Palmer, Tayna Uddin, Thomas O'Grady, Mark Wille, and Courtney Hollowell Stephen HurleyStephen Hurley More articles by this author , Saumya EasawSaumya Easaw More articles by this author , Andrew DragoAndrew Drago More articles by this author , Christina PalmerChristina Palmer More articles by this author , Tayna UddinTayna Uddin More articles by this author , Thomas O'GradyThomas O'Grady More articles by this author , Mark WilleMark Wille More articles by this author , and Courtney HollowellCourtney Hollowell More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.369AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Approximately half of patients who smoke at the time of their cancer diagnosis quit prior to treatment. However, a large percentage of patients continue to smoke or relapse after quitting. Genitourinary (GU) cancer patients who continue to smoke are at increased risk for recurrence, poor survival rates, treatment complications, second primary cancers, and other chronic smoking related illnesses. Smoking cessation after GU cancer diagnosis is a critical component of survivorship, however factors related to continued smoking are understudied. The purpose of this study is to identify the rates and clinical variables that are predictors for continued smoking among patients diagnosed with a GU malignancy. METHODS A cross-sectional study of a convenience sample was conducted with participants who either quit or continued to smoke after the diagnosis of a GU malignancy. Nonsmokers or past smokers who had quit smoking before their cancer diagnosis were excluded. A self-reported questionnaire included patient demographics, smoking behaviors, perceived social support (validated Duke-UNC Functional Social Support Questionnaire), fear of cancer recurrence (validated Cancer Worry Scale), and significant anxiety and depression (validated Hospital Anxiety and Depression Scale). Predictors of continued smoking were identified using multivariate logistic regression. RESULTS Among the 204 study participants who were active smokers at the time of GU cancer diagnosis, 90 (44%) were current smokers at the time survey completion. Cancer diagnoses included prostate 66 (32%), kidney 57 (28 %), bladder 57 (28%), testicular 15 (7%), penile 5 (3%), and upper GU tract 4 (2%). Several predictors of continued smoking status were identified, including concern for cancer recurrence (odds ratio (OR) 4.94, 95% confidence interval (CI) 1.81 to 14.97, p= 0.007), anxiety (OR 16.8, 95% CI 5.6 to 57.6, p=0.005), greater than 20-year smoking history (OR 66.5, 95% CI 5.15 to 141.5, p= <0.001), and second-hand smoke exposure in the home (OR 186.3, 95% CI 47.5 to 1279, p=<0.001). CONCLUSIONS Forty-four percent of patients with a GU malignancy who were active smokers at the time of diagnosis continue to smoke despite the associated health risks. Factors associated with continued smoking after diagnosis include anxiety, concern for cancer recurrence, greater than 20-year smoking history, and second-hand smoke exposure in the home. These findings highlight the need for comprehensive smoking cessation interventions for GU cancer patients. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byZhao C, Bjurlin M, Roberts T, Rink M, Shariat S and Matulewicz R (2021) A Systematic Review and Scoping Analysis of Smoking Cessation after a Urological Cancer DiagnosisJournal of Urology, VOL. 205, NO. 5, (1275-1285), Online publication date: 1-May-2021. Volume 193Issue 4SApril 2015Page: e105 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Stephen Hurley More articles by this author Saumya Easaw More articles by this author Andrew Drago More articles by this author Christina Palmer More articles by this author Tayna Uddin More articles by this author Thomas O'Grady More articles by this author Mark Wille More articles by this author Courtney Hollowell More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...